Literature DB >> 25621551

Long-term clinical success of minimally and moderately rough oral implants: a review of 71 studies with 5 years or more of follow-up.

Ryo Jimbo1, Tomas Albrektsson.   

Abstract

PURPOSE: The aim of the review was to compare the long-term clinical success of minimally and moderately rough dental implants in terms of differences in marginal bone loss and survival.
MATERIALS AND METHODS: The pertinent literature was searched by using the PubMed database and requesting major manufacturers to provide reports of their commercially available dental implant systems. Clinical reports meeting the following criteria were reviewed: results of at least 5 years of follow-up, availability of baseline and follow-up radiographs including intraoral radiographs, and availability of marginal bone loss measurements from the baseline to the end of the follow-up period (5 years or more). All the recorded data were analyzed statistically.
RESULTS: Seventy-one of 1202 articles met the inclusion criteria. Maxillary moderately rough implants were found to have significantly higher long-term survival rates than maxillary minimally rough implants; no such difference was noticed in the mandible. Significant marginal bone loss occurred around all the implants in the first year but stabilized thereafter, indicating the absence of progressive bone loss.
CONCLUSION: The dental implant systems commercially available today have good long-term clinical success in terms of survival and marginal bone loss.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25621551     DOI: 10.1097/ID.0000000000000205

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  9 in total

1.  A Simplified Prosthetic Implant Loading Protocol: 1-Year Clinical Follow-Up Study.

Authors:  Lorenzo Andreatta; Malin Bjursten Brailsford; Jakob Zwaan
Journal:  Int J Dent       Date:  2020-08-03

2.  A One-year Follow-up Study of a Tapered Hydrophilic Implant Design Using Various Placement Protocols in the Maxilla.

Authors:  Jakob Zwaan; Leonardo Vanden Bogaerde; Herman Sahlin; Lars Sennerby
Journal:  Open Dent J       Date:  2016-12-09

3.  Titanium biomaterials with complex surfaces induced aberrant peripheral circadian rhythms in bone marrow mesenchymal stromal cells.

Authors:  Nathaniel Hassan; Kirstin McCarville; Kenzo Morinaga; Cristiane M Mengatto; Peter Langfelder; Akishige Hokugo; Yu Tahara; Christopher S Colwell; Ichiro Nishimura
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

4.  On the Cleanliness of Different Oral Implant Systems: A Pilot Study.

Authors:  Dirk U Duddeck; Tomas Albrektsson; Ann Wennerberg; Christel Larsson; Florian Beuer
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

5.  Disproportionate Effect of Sub-Micron Topography on Osteoconductive Capability of Titanium.

Authors:  Juri Saruta; Nobuaki Sato; Manabu Ishijima; Takahisa Okubo; Makoto Hirota; Takahiro Ogawa
Journal:  Int J Mol Sci       Date:  2019-08-18       Impact factor: 5.923

6.  One-Piece Titanium Implants: Retrospective Case Series.

Authors:  Gunar Wagner; Dieter Hartung
Journal:  Case Rep Dent       Date:  2021-04-08

Review 7.  Plasma of Argon Treatment of the Implant Surface, Systematic Review of In Vitro Studies.

Authors:  Massimo Carossa; Davide Cavagnetto; Francesca Mancini; Alessandro Mosca Balma; Federico Mussano
Journal:  Biomolecules       Date:  2022-09-01

Review 8.  Implications of considering peri-implant bone loss a disease, a narrative review.

Authors:  Tomas Albrektsson; Pentti Tengvall; Luis Amengual-Peñafiel; Pierluigi Coli; Georgios Kotsakis; David L Cochran
Journal:  Clin Implant Dent Relat Res       Date:  2022-05-31       Impact factor: 4.259

9.  Cytocompatibility of Titanium, Zirconia and Modified PEEK after Surface Treatment Using UV Light or Non-Thermal Plasma.

Authors:  Linna Guo; Ralf Smeets; Lan Kluwe; Philip Hartjen; Mike Barbeck; Claudio Cacaci; Martin Gosau; Anders Henningsen
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.